Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density

Sponsor
Duramed Research (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT00117260
Collaborator
(none)
0
25

Study Details

Study Description

Brief Summary

This is a randomized, multicenter, placebo-controlled study to evaluate the effects of Seasonale, an extended-regimen oral contraceptive, on bone mineral density in adolescent females who have had their menstrual period but now have secondary amenorrhea and also have osteopenia. The duration of the study for each patient will be approximately two years.

Condition or Disease Intervention/Treatment Phase
  • Drug: Seasonale (levonorgestrel and ethinyl estradiol)
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a 91-Day Extended-Cycle Combination Oral Contraceptive (Seasonale) for the Treatment of Low Bone Mineral Density in Adolescent Females With Secondary Amenorrhea and Osteopenia
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Jul 1, 2007
Actual Study Completion Date :
Aug 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Mean percent change in the lumbar spine bone mineral density at month 12 []

Secondary Outcome Measures

  1. Interim and 24 month mean percent change in lumbar spine bone mineral density []

  2. Mean percent change in the proximal femur (hip) bone mineral density []

  3. Mean percent change in total body bone mineral density []

  4. Mean change in biochemical markers of bone resorption and bone formation []

  5. Change in body weight []

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 17 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Not sexually active and agree to remain sexually inactive throughout the course of the study

  • First menstrual period at least one year ago

  • No menstrual period in the last 6 months

Exclusion Criteria:
  • Undiagnosed abnormal genital bleeding

  • Known or suspected pregnancy

  • Medical history of any disorder that contraindicates the use of oral contraceptives

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Duramed Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00117260
Other Study ID Numbers:
  • SEA-305
First Posted:
Jul 6, 2005
Last Update Posted:
Aug 12, 2013
Last Verified:
Aug 1, 2013

Study Results

No Results Posted as of Aug 12, 2013